Literature DB >> 33759516

Pterostilbene Ameliorates DSS-Induced Intestinal Epithelial Barrier Loss in Mice via Suppression of the NF-κB-Mediated MLCK-MLC Signaling Pathway.

Juan Wang1, Hui Zhao1, Ke Lv1,2, Wei Zhao1, Ning Zhang1, Fan Yang1, Xiang Wen1, Xiaohua Jiang3, Jingrui Tian3, Xinjuan Liu4, Chi-Tang Ho5, Shiming Li2,5.   

Abstract

The integrity of the intestinal barrier is critical for homeostasis. In this study, we investigated the protective effect of pterostilbene (PTE) on the intestinal epithelium barrier. In vitro results of transepithelial electrical resistance (TEER) in Caco-2 cells indicated that PTE counteracted tumor necrosis factor α (TNFα)-induced barrier damage. In vivo PTE pretreatment markedly ameliorated intestinal barrier dysfunction induced by dextran sulfate sodium (DSS). Notably, intestinal epithelial tight junction (TJ) molecules were restored by PTE in mice exposed to DSS. The mechanism study revealed that PTE prevented myosin light-chain kinase (MLCK) from driving phosphorylation of MLC (p-MLC), which is crucial for maintaining intestinal TJ stability. Furthermore, PTE blunted translocation of NF-κB subunit p65 into the nucleus to downregulate MLCK expression and then to safeguard TJs and barrier integrity. These findings suggest that PTE protected the intestinal epithelial barrier through the NF-κB- MLCK/p-MLC signal pathway.

Entities:  

Keywords:  epithelial barrier; intestine; myosin light-chain kinase; pterostilbene; tight junction

Year:  2021        PMID: 33759516     DOI: 10.1021/acs.jafc.1c00274

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  4 in total

1.  Lead exposure exacerbates adverse effects of HFD on metabolic function via disruption of gut microbiome, leading to compromised barrier function and inflammation.

Authors:  Liehai Hu; Yu Zhao; Shanji Liu; Jinfeng Zhang; Tao You; Bei Gan; Hengyi Xu
Journal:  Eur J Nutr       Date:  2022-10-20       Impact factor: 4.865

2.  Oral Delivery of Pterostilbene by L-Arginine-Mediated "Nano-Bomb" Carrier for the Treatment of Ulcerative Colitis.

Authors:  Wei Wei; Yujie Zhang; Runqing Li; Yameng Cao; Xiangji Yan; Yana Ma; Yuanyuan Zhang; Mei Yang; Mingzhen Zhang
Journal:  Int J Nanomedicine       Date:  2022-02-09

3.  Pterostilbene attenuates intestinal epithelial barrier loss induced by high loading intensity of exercise.

Authors:  Lidong Zhang; Guoliang Tian; Li Huang; Min Zhou; Jundong Zhu; Long Yi; Mantian Mi
Journal:  Front Nutr       Date:  2022-08-04

Review 4.  Therapeutic effects and mechanisms of plant-derived natural compounds against intestinal mucositis.

Authors:  Cailan Li; Jianhui Xie; Jiahao Wang; Ying Cao; Min Pu; Qihai Gong; Qiang Lu
Journal:  Front Pharmacol       Date:  2022-09-21       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.